Synthesis and Anti-HIV-1 Activity of a Novel Series of Aminoimidazole Analogs

被引：9

作者：

Ganguly, Swastika ^{[1
]}

Murugesan, Sankaran ^{[1
]}

Prasanthi, Naru ^{[1
]}

Alpturk, Onur ^{[2
]}

Herman, Brian ^{[2
]}

Sluis-Cremer, Nicolas ^{[2
]}

机构：

[1] Birla Inst Technol, Dept Pharmaceut Sci, Ranchi 835215, Jharkhand, India

[2] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA

来源：

LETTERS IN DRUG DESIGN & DISCOVERY | 2010年 / 7卷 / 05期

基金：

美国国家卫生研究院;

关键词：

N-aminoimidazole; NNRTI; HIV; Reverse transcriptase; Synthesis; Molecular modeling; HIV-1; REVERSE-TRANSCRIPTASE; IMMUNODEFICIENCY-VIRUS TYPE-1; NONNUCLEOSIDE INHIBITORS; CONFORMATIONAL-CHANGES; ANGSTROM RESOLUTION; DRUG-RESISTANCE; MECHANISMS; REPLICATION; MUTATIONS;

D O I：

10.2174/157018010791163424

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

There is still an urgent need to develop nonnucleoside reverse transcriptase (RT) inhibitors (NNRTI) with a high-genetic barrier to resistance that facilitate patient adherence and allow durable suppression of HIV-1 replication. In this study, we describe the synthesis of a novel series of N-aminoimidazole (NAIM) analogs. Each of the NAIM analogs display potent activity against wild-type recombinant purified HIV-1 RT as well as RTs containing the K103N or Y181C resistance mutations. The analogs, however, do not exhibit significant antiviral activity in cell culture and were, in general, cytotoxic. Nevertheless, these data suggest that the NAIM backbone may provide a suitable scaffold from which inhibitors active against NNRTI-resistant HIV-1 could be developed.

引用

页码：318 / 323

页数：6

共 22 条

[11] N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action
Lagoja, IM
Pannecouque, C
Van Aerschot, A
Witvrouw, M
Debyser, Z
Balzarini, J
Herdewijn, P
De Clercq, E
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) : 1546 - 1553
[12] LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X
[13] LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x
[14] Slide into Action: Dynamic Shuttling of HIV Reverse Transcriptase on Nucleic Acid Substrates
Liu, Shixin
Abbondanzieri, Elio A.
Rausch, Jason W.
Le Grice, Stuart F. J.
Zhuang, Xiaowei
[J]. SCIENCE, 2008, 322 (5904) : 1092 - 1097
[15] Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT
Nissley, Dwight V.
Radzio, Jessica
Ambrose, Zandrea
Sheen, Chih-Wei
Hamamouch, Noureddine
Moore, Katie L.
Tachedjian, Gilda
Sluis-Cremer, Nicolas
[J]. BIOCHEMICAL JOURNAL, 2007, 404 : 151 - 157
[16] In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase
Parikh, UM
Koontz, DL
Chu, CK
Schinazi, RF
Mellors, JW
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 1139 - 1144
[17] Reed L. J., 1938, AM J HYG, V27, P493
[18] Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors
Ren, J
Nichols, C
Bird, L
Chamberlain, P
Weaver, K
Short, S
Stuart, DI
Stammers, DK
[J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 312 (04) : 795 - 805
[19] Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase
Ren, Jingshan
Stammers, David K.
[J]. VIRUS RESEARCH, 2008, 134 (1-2) : 157 - 170
[20] Anti-Human Immunodeficiency Virus Activity, Cross-Resistance, Cytotoxicity, and Intracellular Pharmacology of the 3′-Azido-2′,3′-Dideoxypurine Nucleosides
Sluis-Cremer, Nicolas
Koontz, Dianna
Bassit, Leda
Hernandez-Santiago, Brenda I.
Detorio, Mervi
Rapp, Kim L.
Amblard, Franck
Bondada, Lavanya
Grier, Jason
Coats, Steven J.
Schinazi, Raymond F.
Mellors, John W.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) : 3715 - 3719

← 1 2 3 →